From Clinical Thyroidology for the Public: THYROID CANCER Radioactive iodine doses exceeding 100 mCi increase…
Read More
The Washington Post – by Emily Mullin, September 7, 2015 Robert Smallridge, deputy director of…
Thyroid is proud to announce our new impact factor of 4.493, a 17% increase over…
Thyroid is proud to announce our new impact factor of 4.493, a 17% increase over…
New Rochelle, NY, April 22, 2015—Previous guidelines from the American Thyroid Association (ATA) for evaluating…
Hosted by Dana-Farber Cancer Institute (DFCI) and the American Thyroid Association (ATA).Tuesday, April 14 from…
New Rochelle, NY, March 26, 2015—A Task Force convened by the American Thyroid Association (ATA)…
Eisai is pleased to announce that LENVIMATM (lenvatinib)is now approved for the treatment of locally…
On February 13, 2015, the U. S. Food and Drug Administration approved lenvatinib (LENVIMA) for…
From the American Thyroid Association: In collaboration with the Food and Drug Administration (FDA), and…
AMERICAN THYROID ASSOCIATION® , ATA® , THYROID® , CLINICAL THYROIDOLOGY® , and the distinctive circular logo are registered in the U.S. Patent and Trademark Office as trademarks of the American Thyroid Association® , Inc.